Alpha DNA Investment Management »

Adma Biologics shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $605k 92k 6.60

More positions owned by Alpha DNA Investment Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Chubb (CB)
McDonald's Corporation (MCD)
Mondelez Intl Cl A (MDLZ)
Merck & Co (MRK)
Wal-Mart Stores (WMT)
Union Pacific Corporation (UNP)
Wells Fargo & Company (WFC)
Apple (AAPL)
Cigna Corp (CI)
Bank of America Corporation (BAC)
Nextera Energy (NEE)

View all positions for Alpha DNA Investment Management

Top funds holding Adma Biologics

BlackRock
Vanguard Group
Nuveen Asset Management
American Century Companies
Perceptive Advisors
AWM Investment Company
D. E. Shaw & Co
Geode Capital Management
Two Sigma Investments
Morgan Stanley
Dimensional Fund Advisors
Two Sigma Advisers
Ophir Asset Management Pty
Assenagon Asset Management
Deutsche Bank Aktiengesellschaft

View all funds holding Adma Biologics